IL-33-mediated protection against experimental cerebral malaria is linked to induction of type 2 innate lymphoid cells, M2 macrophages and regulatory T cells.
about
Innate cell communication kick-starts pathogen-specific immunityInterleukin-1 Family Cytokines in Liver DiseasesCharacterization of meningeal type 2 innate lymphocytes and their response to CNS injury.IL-33 receptor ST2 regulates the cognitive impairments associated with experimental cerebral malariaInterleukin-33 regulates intestinal inflammation by modulating macrophages in inflammatory bowel disease.Regulatory immune cells in regulation of intestinal inflammatory response to microbiota.Vaccination against IL-33 Inhibits Airway Hyperresponsiveness and Inflammation in a House Dust Mite Model of AsthmaInterleukin-33 in Tissue Homeostasis, Injury, and InflammationCytokine response during non-cerebral and cerebral malaria: evidence of a failure to control inflammation as a cause of death in African adultsEmerging concepts and future challenges in innate lymphoid cell biologyIL-4-producing ILC2s are required for the differentiation of TH2 cells following Heligmosomoides polygyrus infection.M2 macrophages or IL-33 treatment attenuate ongoing Mycobacterium tuberculosis infection.Role of the IL-33-ST2 axis in sepsis.Regulatory T cell frequency, but not plasma IL-33 levels, represents potential immunological biomarker to predict clinical response to intravenous immunoglobulin therapy.The Roles of Mast Cells in Parasitic Protozoan Infections.Group 2 innate lymphoid cells in disease.Lewis Lung Cancer Cells Promote SIGNR1(CD209b)-Mediated Macrophages Polarization Induced by IL-4 to Facilitate Immune Evasion.Interleukin-33 in health and disease.The Impact of Established Immunoregulatory Networks on Vaccine Efficacy and the Development of Immunity to Malaria.Hypoxia inducible factor-1α-induced interleukin-33 expression in intestinal epithelia contributes to mucosal homeostasis in inflammatory bowel disease.IL-33 delivery induces serous cavity macrophage proliferation independent of interleukin-4 receptor alpha.Helminth Regulation of Immunity: A Three-pronged Approach to Treat Colitis.IL-10-producing, ST2-expressing Foxp3+ T cells in multiple sclerosis brain lesions.IL-33-Mediated Expansion of Type 2 Innate Lymphoid Cells Protects from Progressive Glomerulosclerosis.Cannabinoid Receptor 2 Modulates Susceptibility to Experimental Cerebral Malaria through a CCL17-dependent Mechanism.The IL-33 receptor (ST2) regulates early IL-13 production in fungus-induced allergic airway inflammation.Myeloid expression of the AP-1 transcription factor JUNB modulates outcomes of type 1 and type 2 parasitic infections.IL-25, IL-33 and TSLP receptor are not critical for development of experimental murine malaria.IL-33 blockade suppresses tumor growth of human lung cancer through direct and indirect pathways in a preclinical model.ILC2-modulated T cell-to-MDSC balance is associated with bladder cancer recurrence.Dual-targeting Theranostic System with Mimicking Apoptosis to Promote Myocardial Infarction Repair via Modulation of Macrophages.Interactions between Innate Lymphoid Cells and Cells of the Innate and Adaptive Immune System.A bite to fight: front-line innate immune defenses against malaria parasites.Potentiating Tissue-Resident Type 2 Innate Lymphoid Cells by IL-33 to Prevent Renal Ischemia-Reperfusion Injury.Janus-Faced Myeloid-Derived Suppressor Cell Exosomes for the Good and the Bad in Cancer and Autoimmune Disease.Critical Roles of IL-33/ST2 Pathway in Neurological Disorders.Targeting the IL33-NLRP3 axis improves therapy for experimental cerebral malaria
P2860
Q26752790-9FC84CCE-6B6B-422C-97B5-5E963511D3BDQ26778553-9196FE0D-C753-4D5E-A9E2-49833A679F61Q30275187-EC243260-99BD-4AC9-8EAD-857095967C48Q33610655-E326BADD-D1EA-41B6-A249-672EF73B20F8Q33678403-3CD946BD-2DC9-4F0A-8E23-F7409922C6CCQ35665218-76330C1F-B632-4E08-A95A-BEDB4950CCDCQ35716467-B34511A4-457D-41C7-80B4-A460E21AC601Q35754479-8534AA5C-01E9-4649-A9AB-E93A4E5F0202Q36881040-DABACB3A-368E-47CF-A96C-DBCEFBE477A0Q37346684-3ACAA6A0-8038-4306-9A32-002E62C650CCQ37600819-CBA74AF0-4281-474B-B00C-D86AF37239D2Q37609295-1348759D-C2B4-478A-87A3-0A1CD195E798Q37620811-C22BEC07-8F2E-4B42-BC8B-26FBF71B52ECQ37713650-CE814915-BA29-4CEB-B22D-9AA74E620113Q37739125-1C44F0B9-1B39-4745-BA5E-29C843F2A882Q38573631-CE4A1313-92AD-48D1-8A3B-835171CE1149Q38829563-D04441E1-972E-4A9B-87D3-70C9308163DAQ38957840-E56B8DFC-3F8F-43D1-91DD-7462FB001E5AQ39027956-6996198B-4C45-4EF2-87AD-EB43DC535883Q39127691-C81AED4F-363D-4AAC-81F6-CD6128444C2EQ39424408-DFBACD33-4074-4DAA-A809-837A4BB7BD2CQ39440518-B7EDF186-E6D3-4877-A19E-2C9AB21A96B5Q40341909-2546DD70-0EB9-43CB-8EF8-D398515E313FQ40348061-7D420BE1-A8EC-40C9-8973-682503FD9344Q40594444-C0E91EFE-EDC4-4459-A4CE-7E5896248D2CQ40915156-47835465-072B-4133-8811-6906CEB7CE58Q41106752-25217A03-C8F7-46D7-B7B9-137D08AACB2BQ41683362-39CF4227-5CC5-45F6-A794-13CDE7E7B20DQ41972983-35F47034-4987-4C5A-B60C-801913E13F3FQ42910010-FBDDD7F2-2A85-4296-9857-0CC5DA2DF76BQ43593252-8F9EF665-3DD7-4535-89BA-FD7E53C4AD46Q47186385-375ACCA1-BBC8-487B-8621-A7A1B849569DQ48023674-FFC3BA55-BFF3-49BA-81E7-E410E50EE5F4Q48319320-D2B83D08-89BD-42D9-9CFA-2C1F17ED4887Q49884887-92D5DC6A-F396-4A56-9838-730BD7E0022BQ54261778-075CBA3E-B596-42A2-9330-84C0488C98FDQ56363934-8E5C1594-6267-49CE-8DD9-0A1DC5A64F97
P2860
IL-33-mediated protection against experimental cerebral malaria is linked to induction of type 2 innate lymphoid cells, M2 macrophages and regulatory T cells.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
IL-33-mediated protection agai ...... phages and regulatory T cells.
@ast
IL-33-mediated protection agai ...... phages and regulatory T cells.
@en
type
label
IL-33-mediated protection agai ...... phages and regulatory T cells.
@ast
IL-33-mediated protection agai ...... phages and regulatory T cells.
@en
prefLabel
IL-33-mediated protection agai ...... phages and regulatory T cells.
@ast
IL-33-mediated protection agai ...... phages and regulatory T cells.
@en
P2093
P2860
P50
P1433
P1476
IL-33-mediated protection agai ...... phages and regulatory T cells.
@en
P2093
Anne-Gaelle Besnard
Flora Reverchon
Jennifer Palomo
Wanda Niedbala
P2860
P304
P356
10.1371/JOURNAL.PPAT.1004607
P577
2015-02-06T00:00:00Z